By
Aaron Nicodemus2020-03-25T15:11:00
As infections stemming from the coronavirus pandemic continue to mount around the world, publicly traded companies face questions about when and where to disclose that their CEO or other key executives have contracted the virus.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2020-05-15T15:26:00Z By Jaclyn Jaeger
The Advanced Medical Technology Association has released new compliance guidance for medical-technology companies to guide them in mitigating compliance and corruption risks as they help healthcare providers fight coronavirus.
2020-04-09T17:47:00Z By Kyle Brasseur
With the close of the first quarter and earnings releases and investor calls around the corner, senior leadership at the SEC is pushing for full disclosure transparency regarding impact of the coronavirus pandemic.
2020-03-27T16:51:00Z By Jaclyn Jaeger
The SEC’s Division of Corporation Finance published guidance to provide clarity regarding its view on disclosure and other securities law obligations during the escalating coronavirus pandemic.
2026-01-06T12:00:00Z By Ruth Prickett
Payment service providers operating in the EU will have to cover customers’ losses from fraud if their fraud protection regimes are inadequate or poorly implemented under new EU rules.
2025-12-30T07:00:00Z By Ruth Prickett
In 2025, the regulatory focus on greenwashing intensified globally. This trend is set to accelerate in 2026, and compliance has a key part to play in ensuring corporate statements are honest.
2025-12-30T07:00:00Z By Neil Hodge
Companies looking for greater certainty about how they might avoid criminal prosecution for bribery, fraud, and corruption offences may find they’re going to be disappointed if they’re looking for definitive answers in the latest guidance from the U.K.’s main fraud investigator, say experts.
Site powered by Webvision Cloud